4.8 Review

Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury

Carmine Gambino et al.

Summary: This study suggests that uNGAL is a useful biomarker for distinguishing different types of kidney injury, predicting the response to terlipressin and albumin in HRS-AKI patients, and predicting in-hospital mortality in patients with AKI.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit

Rakhi Maiwall et al.

Summary: This study developed a dynamic model called PIRO-CIC for predicting mortality and determining futility of care in critically ill patients with cirrhosis. The model incorporated various factors including coagulation function, kidney function, and inflammatory response. The results showed that the PIRO-CIC model accurately predicted one-month mortality and outperformed other prognostic scores. The limitations of the study were its inapplicability to acute-on-chronic liver failure and patients requiring emergency liver transplant.

HEPATOLOGY INTERNATIONAL (2023)

Review Gastroenterology & Hepatology

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis

Gabriel Mezzano et al.

Summary: The study revealed high global prevalence and mortality rates of ACLF, with regional variations possibly explained by triggers/aetiology of CLD or grade.
Article Cell Biology

Performance of High Mobility Protein Group 1 and Interleukin-6 as Predictors of Outcomes Resulting from Variceal Bleeding in Patients with Advanced Chronic Liver Disease

Camilla Dos Santos Pinheiro et al.

Summary: The study evaluated the performance of HMG1 and IL-6 as predictors of AKI, infection, and death in cirrhotic patients with variceal bleeding. HMG1 was found to be associated with AKI and infection, while IL-6 showed good performance in infection and death outcomes. This data will be useful for comparisons and potential future validations.

INFLAMMATION (2022)

Editorial Material Gastroenterology & Hepatology

Proposing a Framework to Assess the Methodological Quality of Prognostic Models

Ruben Hernaez

LIVER TRANSPLANTATION (2022)

Article Gastroenterology & Hepatology

Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death

Mathias Jachs et al.

Summary: This study found that changes in VWF induced by NSBB therapy are associated with anti-inflammatory activity, accompanied by reduced adverse effects on systemic hemodynamics, and independently associated with decreased risks of further decompensation, ACLF, and death in DC patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension

David Bauer et al.

Summary: This study investigated the impact of HCV-cure on cytokines related to angiogenesis and fibrogenesis and whether their changes reflect the evolution of portal hypertension (PH) and its complications. The results showed that HCV-cure decreases circulating Ang2 and TGF-beta. The dynamics of Ang2 mirrors the progression of PH and can be used as a non-invasive test to predict PH and hepatic decompensation.

DIGESTIVE AND LIVER DISEASE (2022)

Article Gastroenterology & Hepatology

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis

Adria Juanola et al.

Summary: This study found that in patients with decompensated cirrhosis, urinary L-FABP levels are independently associated with the 3-month clinical course and can predict mortality and ACLF development.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators

Elena Curakova Ristovska et al.

Summary: The study found that vWF is significantly related to other prognostic indicators in patients with liver cirrhosis and is a significant predictor of 3-mo, 6-mo, and 1-year mortality similar to MELD score and CRP.

WORLD JOURNAL OF HEPATOLOGY (2022)

Article Pharmacology & Pharmacy

Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With Hepatitis B Cirrhosis and AKI

Zhonghui Duan et al.

Summary: Urinary biomarkers can be useful in differentiating between PRA and other types of AKI in patients with hepatitis B cirrhosis. Elevated urinary NGAL can reflect the degree of kidney injury and is an independent risk factor for nonresponse to volume expansion therapy in patients with hepatitis B cirrhosis and AKI.

FRONTIERS IN PHARMACOLOGY (2022)

Article Geriatrics & Gerontology

Serum Cystatin C as a Predictor of Mortality in Elderly Patients with Liver Cirrhosis and Normal Serum Creatinine

Ibrahim Mohamed Fouad Zaki et al.

Summary: This study aimed to investigate the predictive efficacy of serum cystatin C level for one-year mortality in elderly patients with liver cirrhosis. The results showed that serum cystatin C level is an independent predictor of mortality in elderly patients with liver cirrhosis.

AGING MEDICINE AND HEALTHCARE (2022)

Article Gastroenterology & Hepatology

Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome

Laura Napoleone et al.

Summary: Impairment of kidney function is common in acute-on-chronic liver failure (ACLF). Most patients with ACLF have associated acute kidney injury (AKI), sometimes with chronic kidney disease (CKD). In patients without ACLF, the occurrence of AKI is lower, but the prevalence of CKD is similar. AKI in ACLF is associated with poor kidney and patient outcomes.

HEPATOLOGY COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation

Henning Gronbaek et al.

Summary: This study demonstrates that specific inflammatory markers in combination with clinical scores can better predict survival in ACLF patients than the original scoring systems. The findings suggest a key role of macrophage activation and inflammation in the development and progression of ACLF.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

Dalila Costa et al.

Summary: This study revealed significant differences in liver function, portal hypertension, and systemic inflammation among patients with advanced chronic liver disease at different prognostic stages, with IL-6 levels proving to be predictive of decompensation and mortality risk in decompensated patients.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications

Maurizio Baldassarre et al.

Summary: This study evaluated the effective albumin concentration (eAlb) in patients with decompensated cirrhosis, finding that eAlb is more valuable than total albumin concentration (tAlb) in assessing disease severity and prognosis. Additionally, eAlb was better at predicting the occurrence of ACLF and mortality rates.

HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Patterns of dendritic cell and monocyte subsets are associated with disease severity and mortality in liver cirrhosis patients

Chandra Chiappin Cardoso et al.

Summary: The study revealed significant disturbances in circulating monocytes and dendritic cells in cirrhotic patients, with unstable cirrhosis patients showing higher frequencies of specific cell subsets. These changes in cell subsets may be associated with disease severity and mortality rates.

SCIENTIFIC REPORTS (2021)

Article Gastroenterology & Hepatology

MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era

W. Ray Kim et al.

Summary: The final MELD 3.0 model had better discrimination than MELDNa and accurately predicted mortality, particularly in female patients. It addresses determinants of wait list outcomes, including sex disparity, resulting in fewer wait list deaths compared to MELDNa.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes

Lukas Hartl et al.

Summary: The cardiovascular hormones renin, proBNP, and AVP are activated as advanced chronic liver disease and portal hypertension progress. Renin activation is a risk factor for hepatic decompensation and mortality, especially in compensated patients, while elevated copeptin levels predict mortality, particularly in decompensated patients.

HEPATOLOGY INTERNATIONAL (2021)

Article Medicine, General & Internal

Value of shear wave elastography in predicting hepatorenal syndrome in patients with liver cirrhosis and ascites

Yanpeng Fang et al.

Summary: This study found that SWE can indicate renal injury in patients with cirrhosis and ascites, and the combination of YM and RI has a good predictive value for the occurrence of HRS.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Review Medicine, General & Internal

Liver cirrhosis

Pere Gines et al.

Summary: Cirrhosis is a widespread disease with various causes, leading to portal hypertension, systemic inflammation, and liver failure. Early diagnosis and management of complications are crucial to prevent progression to decompensated cirrhosis. Liver transplantation may be necessary in severe cases.

LANCET (2021)

Letter Gastroenterology & Hepatology

Comment on Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis

Fangbin Weng

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Serum cystatin C as a predictor of 90-day mortality among patients admitted with complications of cirrhosis

Anuchit Suksamai et al.

Summary: This study compared the predictive performance of serum Cys level and MELD score in predicting 90-day mortality among patients with cirrhosis, finding that serum Cys was superior to MELD score. A new MELD-Cys model was developed, which showed comparable predictive ability to the MELD score.

JGH OPEN (2021)

Article Gastroenterology & Hepatology

Cystatin C and interleukin-6 for prognosticating patients with acute decompensation of cirrhosis

Gaurav Padia et al.

Summary: This study suggests that in patients with acute decompensation of cirrhosis, serum CysC can predict the development of renal dysfunction and acute-on-chronic liver failure. Serum IL-6, on the other hand, was not found to be an independent predictor of these outcomes.

JGH OPEN (2021)

Article Gastroenterology & Hepatology

Sex specificity of kidney markers to assess prognosis in cirrhotic patients with TIPS

Maria Torner et al.

LIVER INTERNATIONAL (2020)

Article Gastroenterology & Hepatology

Albumin in decompensated cirrhosis: new concepts and perspectives

Mauro Bernardi et al.

Article Gastroenterology & Hepatology

Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure

Michael Praktiknjo et al.

LIVER INTERNATIONAL (2020)

Article Cell Biology

Evaluation of the Biomarkers HMGB1 and IL-6 as Predictors of Mortality in Cirrhotic Patients with Acute Kidney Injury

Celio Geraldo de Oliveira Gomes et al.

MEDIATORS OF INFLAMMATION (2020)

Article Urology & Nephrology

Utility of Urinary Neutrophil gelatinase associated lipocalin (NGAL) in decompensated cirrhosis

S. Sai Krishna Reddy et al.

INDIAN JOURNAL OF NEPHROLOGY (2020)

Article Urology & Nephrology

Could KIM-1 and NGAL levels predict acute kidney injury after paracentesis? - preliminary study

Marta Pietrukaniec et al.

RENAL FAILURE (2020)

Article Gastroenterology & Hepatology

Validation of a Model for Identification of Patients With Compensated Cirrhosis at High Risk of Decompensation

Indra Neil Guha et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Biotechnology & Applied Microbiology

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis

JianPing Wu et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Article Medical Laboratory Technology

Copeptin - a biomarker of short-term mortality risk (7 days) in patients with end-stage liver disease

Christoph Schneider et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

Editorial Material Gastroenterology & Hepatology

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Shiv Kumar Sarin et al.

HEPATOLOGY INTERNATIONAL (2019)

Article Computer Science, Interdisciplinary Applications

The REDCap consortium: Building an international community of software platform partners

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2019)

Article Gastroenterology & Hepatology

Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

Christian Labenz et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Multidisciplinary Sciences

Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis

Sang Kyung Jo et al.

SCIENTIFIC REPORTS (2019)

Article Gastroenterology & Hepatology

IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure

Katharina Schwarzkopf et al.

HEPATOLOGY COMMUNICATIONS (2019)

Article Gastroenterology & Hepatology

Cell death markers in patients with cirrhosis and acute decompensation

Stewart Macdonald et al.

HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites

Yeon Seok Seo et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Medicine, General & Internal

Hepatorenal syndrome

Pere Gines et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Gastroenterology & Hepatology

Acute-on-chronic liver failure: an update

Ruben Hernaez et al.

Article Gastroenterology & Hepatology

AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure

Rakhi Maiwall et al.

HEPATOLOGY INTERNATIONAL (2017)

Article Multidisciplinary Sciences

Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes

Isabel Graupera et al.

SCIENTIFIC REPORTS (2017)

Article Gastroenterology & Hepatology

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis

Desmond Y. H. Yap et al.

DIGESTIVE AND LIVER DISEASE (2017)

Article Gastroenterology & Hepatology

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis

Elsa Sola et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia

Georgios N. Kalambokis et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Circulating insulin-like growth factor-binding protein 3 as prognostic biomarker in liver cirrhosis

Carina Gabriela Correa et al.

WORLD JOURNAL OF HEPATOLOGY (2016)

Letter Medicine, General & Internal

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)

Harry B. Burke

ANNALS OF INTERNAL MEDICINE (2015)

Article Medicine, General & Internal

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

Patrick M. Bossuyt et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Medicine, General & Internal

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

Patrick M. Bossuyt et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Multidisciplinary Sciences

Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis

Xavier Ariza et al.

PLOS ONE (2015)

Article Multidisciplinary Sciences

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis

Annarein J. C. Kerbert et al.

PLOS ONE (2015)

Article Gastroenterology & Hepatology

Survival in Infection-Related Acute-on-Chronic Liver Failure Is Defined by Extrahepatic Organ Failures

Jasmohan S. Bajaj et al.

HEPATOLOGY (2014)

Article Medicine, General & Internal

Lipopolysaccharide binding protein in cirrhotic patients with severe sepsis

Yi-Yuan Chen et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2014)

Article Gastroenterology & Hepatology

Cardiac and proinflammatory markers predict prognosis in cirrhosis

Signe Wiese et al.

LIVER INTERNATIONAL (2014)

Article Hematology

Human Nonmercaptalbumin-2: A Novel Prognostic Marker in Chronic Liver Failure

Rudolf E. Stauber et al.

THERAPEUTIC APHERESIS AND DIALYSIS (2014)

Article Medicine, General & Internal

Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine

Bilyana Hristova Teneva et al.

CENTRAL EUROPEAN JOURNAL OF MEDICINE (2014)

Article Gastroenterology & Hepatology

Acute renal failure in cirrhotic patients with severe sepsis: Value of urinary interleukin-18

Ming-Hung Tsai et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Plasma copeptin, a possible prognostic marker in cirrhosis

Jose-Philippe Moreno et al.

LIVER INTERNATIONAL (2013)

Article Gastroenterology & Hepatology

High serum levels of free cortisol indicate severity of cirrhosis in hemodynamically stable patients

Thierry Thevenot et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis

Mohammed A. Sharawey et al.

HEPATOLOGY INTERNATIONAL (2011)

Article Health Care Sciences & Services

Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods

Jan O. Friedrich et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Article Gastroenterology & Hepatology

Evidence-based incorporation of serum sodium concentration into MELD

Scott W. Biggins et al.

GASTROENTEROLOGY (2006)

Review Medicine, General & Internal

Evaluation of the quality of prognosis studies in systematic reviews

JA Hayden et al.

ANNALS OF INTERNAL MEDICINE (2006)

Article Gastroenterology & Hepatology

A model to predict survival in patients with end-stage liver disease

PS Kamath et al.

HEPATOLOGY (2001)